Asensus Surgical, Inc.
ASXC
AMEX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.21M | 1.12M | 5.43M | 1.09M | 1.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.21M | 1.12M | 5.43M | 1.09M | 1.08M |
| Cost of Revenue | 2.66M | 3.06M | 4.27M | 2.87M | 3.07M |
| Gross Profit | -452.00K | -1.93M | 1.17M | -1.78M | -1.99M |
| SG&A Expenses | 9.65M | 8.02M | 7.77M | 8.71M | 9.57M |
| Depreciation & Amortization | 110.00K | 114.00K | 113.00K | 114.00K | 114.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.05M | 19.28M | 20.77M | 20.98M | 21.74M |
| Operating Income | -17.84M | -18.15M | -15.33M | -19.89M | -20.66M |
| Income Before Tax | -25.67M | -22.45M | -17.06M | -18.26M | -20.67M |
| Income Tax Expenses | 75.00K | 46.00K | 178.00K | 57.00K | -12.00K |
| Earnings from Continuing Operations | -25.75M | -22.50M | -17.24M | -18.32M | -20.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.75M | -22.50M | -17.24M | -18.32M | -20.66M |
| EBIT | -17.84M | -18.15M | -15.33M | -19.89M | -20.66M |
| EBITDA | -16.89M | -17.20M | -14.35M | -19.03M | -19.71M |
| EPS Basic | -0.09 | -0.08 | -0.07 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | -0.09 | -0.08 | -0.07 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 272.32M | 269.27M | 264.35M | 256.18M | 239.57M |
| Average Diluted Shares Outstanding | 272.32M | 269.27M | 264.35M | 256.18M | 239.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
